Sign In
Buy EGRX
$0.460
+0 (+0%)
At Close: Jun 03, 2026
Eagle Pharmaceuticals Inc (NASDAQ: EGRX) Q1 2020 Earnings Call Transcript | AlphaStreet
05:32pm, Monday, 11'th May 2020
Final earnings conference call transcript of Eagle Pharmaceuticals Inc. - EGRX stock
Eagle Pharmaceuticals Inc (EGRX) Q1 2020 Earnings Call Transcript
04:30pm, Monday, 11'th May 2020
At this time, I'd like to welcome everyone to Eagle Pharmaceuticals' First Quarter 2020 Earnings Results Conference Call. It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Rel
Eagle Pharmaceuticals (EGRX) Q1 Earnings Surpass Estimates
12:35pm, Monday, 11'th May 2020
Eagle Pharmaceuticals (EGRX) delivered earnings and revenue surprises of 78.72% and -3.63%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Eagle Pharmaceuticals: Q1 Earnings Insights
12:14pm, Monday, 11'th May 2020
Shares of Eagle Pharmaceuticals (NASDAQ:EGRX) remained unaffected at $55.02 after the company reported Q1 results.Quarterly Results Earnings per share decreased 16.83% year over year to $0.84, which b
A Look At The Fair Value Of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)
11:22am, Monday, 11'th May 2020
In this article we are going to estimate the intrinsic value of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) by taking...
Eagle Pharmaceuticals Q1 EPS $0.84 Beats $0.57 Estimate, Sales $46.020M Miss $51.100M Estimate
11:04am, Monday, 11'th May 2020Eagle Pharmaceuticals Reports First Quarter 2020 Results
10:50am, Monday, 11'th May 2020
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ("Eagle" or the "Company") today announced financial results for the three months ended March 31, 2020.
Eagle Pharmaceuticals Reports First Quarter 2020 Results
12:00am, Monday, 11'th May 2020
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced financial results for the three months ended March 31, 2020. Bus
'This disease is deadly': Doctor's stark message to 'growing complacency'
01:24pm, Sunday, 10'th May 2020
A Teesside doctor has shared his reservations about the Government relaxing the coronavirus regulations in his latest update
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
La Jolla's Path Forward
11:49pm, Friday, 08'th May 2020
Giapreza sales continue to grow at a rather muted speed which may be due to a combination of market size limitations, pricing, and lack of clear benefits. There
Rituximab might have edge on conventional treatment of myasthenia gravis
07:12pm, Friday, 08'th May 2020
(Reuters Health) - Rituximab appears to outperform conventional immunosuppressive therapy in patients with myasthenia gravis, especially those with new-onset disease, according to a retrospective stud
Why Eagle Pharmaceuticals (EGRX) Might Surprise This Earnings Season
12:41pm, Friday, 08'th May 2020
Eagle Pharmaceuticals (EGRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Teva (TEVA) Q1 Earnings Top, Coronavirus-Led Buying Aids Sales
12:00am, Friday, 08'th May 20203 Medical Product Stocks Set to Beat This Earnings Season
10:07am, Thursday, 07'th May 2020
Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on several factors.
